Evidence map›Paper›PMID 42129893›Full record

ReviewJournal of cardiothoracic surgery2026

Advances in endovascular repair for type A aortic dissection.

Kewei Wang, Peng Jiang, Yongpan Cui, Jian He, Zihan Zhang, Xiaole Zhang, Fei Mei

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kewei Wang *Department of Vascular Surgery, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443003, China.
Peng Jiang *Department of Vascular Surgery, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443003, China.
Yongpan CuiDepartment of Vascular Surgery, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443003, China.
Jian HeDepartment of Vascular Surgery, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443003, China.
Zihan ZhangDepartment of Vascular Surgery, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443003, China.
Xiaole ZhangDepartment of Vascular Surgery, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443003, China.
Fei MeiDepartment of Vascular Surgery, the First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443003, China. meifeimeifei1986@126.com.

Funding

Hubei Provincial Health Science and Technology Program WJ2025M048
6 · The paper itself

Abstract

objectiveTo review the current status and advancements of endovascular repair for Type A Aortic Dissection (TAAD), considering its high mortality and the limitations of existing treatments like open surgical repair and hybrid repair.

methodsLiterature review was conducted to gather information on anatomical feasibility studies of various stent grafts, endovascular repair procedures (including aortic valve and ascending aorta repair, aortic arch repair techniques), and the advantages and disadvantages of endovascular repair.

resultsAnatomical feasibility of commercial stent grafts for TAAD is low (4% - 21%), but the combination of stent and valve conceptually has a higher applicability (80%). Modular Endo-Bentall stent grafts have an overall anatomical feasibility of 66.4% for reconstructing coronary arteries. Different techniques for aortic arch repair (hybrid, fenestration, branched stent graft, parallel stenting) have shown various success rates and complications. For aortic arch repair, the technical success rates were 94.2 to 96.4% for fenestration, 98 to 100% for branched stent grafts, and 84 to 99.3% for parallel stents. The 30-day mortality ranged from 0 to 5%, stroke incidence from 0 to 18%, type I endoleak from 0 to 16%, and retrograde dissection from 0 to 5.4%.

conclusionsEndovascular repair of TAAD is highly challenging. There is a lack of standardized and commercially available devices. More extensive clinical studies are needed to validate its safety and efficacy and to drive the development of optimized endovascular solutions.

Indexed as

Aortic DissectionDissection, Ascending AortaEndovascular Aneurysm RepairEndovascular ProceduresHumansStentsAortic ValveEndovascular RepairHybrid RepairOpen Surgical RepairType A Aortic Dissection

Identifiers

PMID42129893
PMCPMC13343785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.